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Label-free Voltammetric Immunosensor for Prostate
Specific Antigen Detection
Ne´lia Oliveira,[a] Estefanı´a Costa-Rama,[a] Subramanian Viswanathan,*[b] Cristina Delerue-Matos,[a]
Lourdes Pereira,[c] and Simone Morais*[a]
Abstract: This work describes a sensitive voltammetric
immunosensor for label-free electroanalysis of the pros-
tate specific antigen (PSA), the main biomarker of
prostate cancer. A gold electrode was firstly modified
with the optimum self-assembled monolayer (SAM), 1,6-
hexanedithiol, followed by the subsequent adsorption of
gold nanoparticles (AuNPs) and, then, the monoclonal
antibody to recognize PSA was immobilized. The influ-
ence of the most significant experimental variables (SAM
type and incubation time, AuNPs deposition, antibody
concentration and bovine serum albumin immobilization)
on the biosensor response was studied by microscopy and
voltammetry techniques. The electroanalytical detection
was based on the interaction between PSA antibody and
PSA via square-wave voltammetry using ferrocyanide/
ferricyanide as electrochemical redox indicator. Using the
proposed immunosensor, PSA was specifically detected
within the linear range between 0.2 and 200 ngmL1 with
0.01 ngmL1 as limit of detection. The immunosensor
allows accurate, reproducible and sensitive (22.7% reduc-
tionmLng1) detection in a concentration range useful for
clinical purposes.
Keywords: Electrochemical immunosensor · Self-assembled monolayer · Gold nanoparticles · Cancer biomarker · Prostate specific
antigen
1 Introduction
Prostate cancer is still a clinical issue considering that it is
the second most common cancer in men and the fifth
leading cause of cancer-related mortality among men with
an estimate of 307000 deaths in 2012 [1,2]. The symptoms
mostly appear in advanced phases of the disease; there-
fore, early diagnostic is undoubtedly desire to reduce
evolution risks and malignancy. Prostate specific antigen
(PSA) is a serine protease, being one of the most
prevalent proteins in semen; it can move into the blood
stream through the basal cells and the basement mem-
brane [3]. Blood PSA concentration is significantly
augmented in prostate cancer patients, because of the
disorder of the prostate gland [3–5]. PSA is used
extensively as a prostate cancer biomarker with the aim of
screen, diagnose, follow-up the response to treatment and
detection of recurrence after definite therapy [4–6]. A
value of PSA higher than the cut-off value (2.5–4 ngmL1)
indicates high probability of prostate cancer [6, 7].
In recent years, immunosensors have been appearing
as a promising approach for biomarker quantification.
Among the different detection strategies, electrochemical
immunosensors have attracted much attention because
they combine the specificity and sensitivity of immuno-
assay procedures, and the simplicity, low cost, as well as
the automatization and miniaturization potential of the
electrochemical measurement systems [4,8–10]. Most of
the developed immunosensors use a label to obtain the
analytical response. However, currently label-free immu-
nosensors are a true alternative since they provide rapid
and accurate analyses while reducing the preparation
steps and, therefore, also improving the analytical pre-
cision [4,11]. A critical aspect for the successful develop-
ment of an electrochemical immunosensor is the antibody
immobilization: the key issue is to immobilize antibodies
at an appropriate concentration, maintain their bioactivity
and promote their immobilization with suitable orienta-
tion to interact favorably with its target antigen [12,13].
Self-assembly provides a simple method to function-
alize metallic electrode surfaces with organic molecules,
which have free anchor groups (thiols, disulfides, amines,
silanes, or acids), by their spontaneous organization onto
the metal surface [14,15]. Thus, self-assembled mono-
layers (SAMs) have been extensively applied as the basis
for electrochemical biosensor development, since they
provide well-ordered assemblies strongly chemisorbed on
substrates (electrodes) that improved the adsorption
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capacity and stability of immobilized components [14,15].
SAMs present several advantages such as easy formation,
flexibility in functional control by changing the tail group
and needed of low amount of biomolecules for immobili-
zation [14,16]. Moreover, SAMs can be coupled with gold
nanoparticles (AuNPs) [13,16–18], which present unique
physico-chemical properties, such as high surface/volume
ratio, high stability and good biological compatibility,
making themselves an ideal base for biosensing platform
[12,19,20]. AuNPs also display excellent conduction
characteristics and are easy to functionalize; AuNPs sur-
face can be coated with an antibody by simple adsorption
maintaining the bioactivity of the adsorbed biomolecules
[21–24]. Thus, AuNPs are particularly interesting from an
electroanalytical point of view to couple interface bio-
logical recognition reactions with electronic signal trans-
duction [19,20,25]. Moreover, AuNPs as sensing platform
can not only immobilize a higher amount of biomolecule,
but as well speed up the electron transfer improving the
analytical signal [12,19].
Lately, a lot of immunoassay methods related to PSA
detection have been reported including enzyme-linked
immunosorbent-assays (ELISA) [26], electrochemical im-
munoassays [24, 27–29], chemiluminescent immunoassays
[30] and bioluminescent immunoassay [31]. Although
those methods are reliable, most of them require long
measurement procedures, high costs, complex equipment,
highly qualified personnel and are not appropriate for
massive decentralized assays. Therefore, nowadays it is
still a challenge to develop simple, low-cost and appro-
priate detection methods for sensitive determination of
PSA levels [6, 32]. In this work, a simple and sensitive
nanostructured label free immunosensor for PSA quantifi-
cation is proposed. The sensor consisted of AuNPs
deposited on the previously 1,6-hexanedithiol (HDT)
modified gold electrode (HDT/Au electrode), followed by
antibody adsorption. The biosensor construction and the
assessment of the immune reaction between the modified
electrode and the biomarker were characterized by cyclic
voltammetry (CV) and square-wave voltammetry (SWV).
2 Experimental
2.1 Reagents and Solutions
Absolute ethanol and hydrochloric acid (HCl) (37%)
were purchased from Carlo Erba Reagents. Sulfuric acid
(H2SO4) (96%), hydrogen peroxide (H2O2) (30%) and
sodium chloride (NaCl; 99%) were delivered by PanReac
AppliChem. Alumina solutions (g-Al2O3) 0.3 mm and
0.05 mm were obtained from Gravimeta. Glycine, potas-
sium hexacyanoferrate (III) (K3Fe(CN)6), potassium hex-
acyanoferrate (II) trihydrate (K4Fe(CN)6·3H2O), potassi-
um hydrogen phosphate (KHPO4), potassium dihydrogen
phosphate (KH2PO4), trisodium citrate dehydrate, gluta-
raldehyde, 1,6-hexanedithiol (HDT), cystamine (CYS), 2-
mercaptoethanol (ME), 3-mercaptopropionic acid (MPA)
solution, N-hydroxysuccinimide (NHS), N-(3-Dimethyla-
minopropyl)-N-ethylcarbodiimide hydrochloride (EDC)
and gold(III) chloride solution (30%) (HAuCl4) were
purchased from Sigma-Aldrich. Bovine serum albumin
fraction V (BSA) was obtained from Acros Organics.
Natural human prostate specific antigen protein (PSA)
(ab78528) and anti-prostate specific antigen (anti-PSA)
mouse monoclonal antibody [5A6] (ab10185) were pur-
chased from Abcam. Ultrapure water used throughout
this work was obtained from a Milli-Q Simplicity 185
system (Merck Millipore). BSA, PSA antibody and PSA
solutions were prepared in 0.1 M PBS pH 7.4 buffer.
2.2 Electrochemical Measurements
Electrochemical measurements were performed with an
Autolab PSTAT 12 potentiostat/galvanostat (Metrohm
Autolab B.V.) controlled by a computer through the
Autolab GPES software version 4.9. A conventional
three-electrode cell was used for all electrochemical
measurements: a polycrystalline gold electrode, BASiMF-
2014, with a surface area of 2.0 mm2 and a diameter of
1.6 mm, as a working electrode; platinum as counter-
electrode; and a Ag jAgCl j3 M KCl reference electrode
to which all potentials are referred.
SWV and CV were performed using Fe(CN)6
3/4 as
electroactive indicator at a concentration of 10 mM in
0.1 M PBS solution (pH 7.4). SWV measurements were
obtained varying the potential from 0.6 to 0.2 V at a
scan rate of 200 mV·s1. The optimal SWV parameters
were a frequency of 50 Hz, amplitude of 20 mV and scan
increment of 4 mV. CV measurements were performed at
50 mVs1 in the same potential range as SWV.
2.3 Immunosensor Development
2.3.1 Pretreatment of Gold Disk Electrode
The surface of the bare Au electrode was polished
repeatedly with 0.3 and 0.05 mm alumina powder on
microfiber cloth. Afterwards, the electrode was rinsed
with water and ultrasonically cleaned in absolute ethanol.
Then, the electrode surface was cleaned by immersion in
piranha solution (H2O2 :H2SO4, 1 : 3 v/v) for 5 min at room
temperature (RT). After that, the electrode was rinsed
with water, and cycled 25 times from 0.2 V to 1.6 V in
0.5 M H2SO4 solution at a scan of 100 mV/s. Finally, a
cleaning step was performed by CV, cycling 25 times from
0.2 V to 1.4 V in 0.5 M KOH at a scan of 100 mV/s.
After a washing step with water, the electrode was ready
to be modified.
2.3.2 Modification with Self-assembled Monolayer
Five different SAMs were studied to modify the gold
electrode. In order to perform the modification, the Au
electrode was immersed, for 12 h at RT, in ethanol
solutions of CYS (0.1 M), CYS+ME (0.1 M of each one),
MPA (1 mM), MPA+ME (1 mM of each one) and HDT
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(1 mM). After rinsing with water to remove any unbound
molecules, the CYS-modified electrodes were immersed in
a 3% glutaraldehyde solution for 30 min, while the MPA-
modified electrodes were immersed in an EDC/NHS
solution (0.02%, w/v, of each one in PBS pH 7.4). For the
HDT-modified gold electrode (HDT/Au), just a washing
step with ethanol and water was required.
After selection of the best SAM-modified electrode to
construct the immunosensor, the incubation time for the
SAM formation at RT was optimized varying from 1 to 2 h.
2.3.3 Synthesis of Gold Nanoparticles and Electrode
Modification
AuNPs were synthesized according to the Turkevich
method [1]. First, 20 mL of HAuCl4 solution were mixed
with 20 mL water. This mixture was heated up, while
being stirred, until boiling. Then, 2 mL of trisodium citrate
0.01% (w/v) were added in two times (231 mL). The
mixture was stirred until the color of solution was changed
to wine-red. The solution was then cooled to RT. The
synthetized AuNPs were characterized by UV-Visible
spectroscopy (UV 1800-Shimadzu, Germany), laser dop-
pler velocimetry and dynamic light scattering (Zetasizer
Nano ZS; Malvern Ltd, UK). To immobilize the AuNPs
on the surface of the HDT/Au electrode, it was immersed
in the AuNPs solution for 2 h. After washing with water
and PBS buffer (0.1 M, pH 7.4), the AuNPs/HDT/Au
electrode was ready to immobilize the PSA antibody. The
bare (Au) and the modified electrodes were characterized
by scanning electron microscopy (SEM; FEI Quanta
400FEGESEM/EDAX Genesis X4M) coupled with an
energy dispersive spectrometer (EDS; EDAX Pegasus
X4M).
2.3.4 Antibody Immobilization
Antibodies against PSA were immobilized by adsorption
depositing 20 mL of anti-PSA solution (prepared in 0.1 M
PBS pH 7.4 buffer) onto the AuNPs/HDT/Au electrode
and placing it to incubate at 4 8C for 12 h. Then, the anti-
PSA/AuNPs/HDT/Au electrode was rinsed with a 0.1 M
glycine solution. At last, in order to block the remaining
adsorption-reactive sites, the anti-PSA/AuNPs/HDT/Au
electrode was immersed in a 20 mgmL1 BSA solution
(prepared in 0.1 M PBS pH 7.4 buffer) for 5 min at 4 8C.
Then, the BSA/anti-PSA/AuNPs/HDT/Au was rinsed with
PBS solution.
2.3.5 Electrochemical Detection of PSA
In order to perform the PSA detection, 10 mL of PSA
solution prepared in 0.1 M PBS pH 7.4 buffer were drop
casted onto the BSA/anti-PSA/AuNPs/HDT/Au electrode.
After a 12 h incubation step at 4 8C, the SWV measure-
ments were carried out.
The cathodic peak current reduction (IpR (%)) was
employed to obtain PSA analytical curves. IpR (%) was
calculated with the equation (1):
IpRð%Þ ¼ ð1ðIp=Ip0ÞÞ  100 ð1Þ
where Ip
0 and Ip were the peak current intensities of
Fe(CN)6
3/4 (used as electroactive indicator at a concen-
tration of 10 mM in 0.1 M PBS solution pH=7.4) before
and after the incubation with PSA, respectively.
2.3.6 Reutilization of the Immunosensor
In order to reuse the immunosensor, after PSA detection
the PSA/BSA/anti-PSA/AuNPs/HDT/Au electrode was
immersed in 0.1 M glycine-HCl solution pH 3 at 4 8C for
20 minutes. Then, the immunosensor, after a rinsing step
with PBS, was ready for a new PSA determination.
3 Results and Discussion
3.1 Immunosensor Development
In Figure 1, the different steps concerning the develop-
ment of the developed PSA immunosensor are schemati-
cally illustrated. In this section, optimization studies of the
different variables involved in the immunosensor con-
struction are presented.
3.1.1 Self-assembled Monolayer Formation
First, five different SAMs (CYS (0.1 M), CYS+ME
(0.1 M each one), MPA (1 mM), MPA+ME (1 mM each
one) and HDT (1 mM)) were selected based on the
different head and tail groups, number of sulfur or thiol
groups and chain length, as well as based on previous
studies [13–15]. One of the key benefits of SAMs is that
their simplicity of preparation; the electrode surface has
to be just immersed in the SAM solution for a given
period followed by washing with the same solvent [15].
Fig. 1. Schematic representation of the different steps needed for
the immunosensor construction.
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The modification of the electrode with each SAM formed
an organic assembly on the electrode surface that blocked
the electron transfer between the electrode surface and
the electroactive species in solution causing a signal
reduction in the peak current. The block in the electron
transfer for the electrodes modified with the different
SAMs was studied using Fe(CN)6
3/4 as redox probe
(Figure S1 in Supplementary Data). For the same time of
modification (12 h), the higher peak current diminution
(97%) was detected for the SAM composed of HDT.
Therefore, among the tested SAMs, HDT-SAM was the
best adsorbed and packed [14,18,34] on the electrode
surface. SAMs of alkanethiols on Au are one of the
simplest way and best available surface modification for
biosensors development since sulfur has strong affinity to
Au and van der Waals inter-chain interactions ensure
SAM tight packing and stability [13–15]. Moreover, since
HDT has two SH groups (one head group and a tail
group), it will facilitate the immobilization of the AuNPs
(Figure 1). Thus, the HDT/Au electrode was the selected
to develop the immunosensor.
Afterward, the impact of the incubation time on the
HDT-SAM formation was studied. Short incubation times
were tested (1 and 2 h) with the aim of achieving the
electrode modification in the shorter time possible. Fig-
ure 2 shows the SWV recorded in the redox indicator
(Fe(CN)6
3/4) for the Au electrode without modification
and for the Au electrode modified with HDT-SAM for the
tested times. As it can be seen in Figure 2, when an
incubation time of 2 h was employed, a nearly total block
of the electron transfer (88% for 1 h and 96% for 2 h,
which is similar to the achieved with 12 h, Figure S1) was
obtained indicating that this duration is enough to form
an organized and packed SAM of HDT on the Au
electrode surface. Overall, this optimized incubation time
is short when compared with most data found in literature
(from 30 min to 24 h) [12,17,29,32,35–37].
3.1.2 Characterization of AuNPs and AuNPs/HDT/Au
Electrode
The synthetized AuNPs presented a mean hydrodynamic
diameter of 36 nm and an average zeta potential of
35 mV, which suggest a stable suspension with low
tendency to aggregation [38,39]. The AuNPs were also
characterized by UV-VIS (Figure S2 in Supplementary
Data), which spectra exhibited the typical band at 522 nm
for AuNPs stabilized by citrate ions that confirms their
low size [40–42].
Cyclic voltammograms were recorded in 10 mM
Fe(CN)6
3/4 solution (in PBS 0.1 M pH 7.4) at a scan rate
of 50 mV·s1 employing the Au electrode without mod-
ification, the HDT/Au electrode and the AuNPs/HDT/Au
electrode (Figure 3A), with the aim of determining if the
modification with AuNPs allowed to recover the peak
current obtained for the Au electrode before SAM
modification. Accordingly, with previously reported works
[43,44], the modification of the HDT/Au electrode with
the AuNPs enhanced the intensity of the peak. As
Figure 3A shows, almost the same peak current was
obtained for the Au electrode and for the AuNPs/HDT/
Au electrode. The successful electrode modification with
AuNPs was also confirmed by SEM (Figure 3B–C) that
showed an irregular surface with the AuNPs densely and
well-distributed on the SAM-modified Au electrode; EDS
characterization corroborated these findings (Figure 3D).
Thus, electrochemical and optical techniques demon-
strated the effective AuNPs/HDT/Au electrode modifica-
tion.
3.1.3 Antibody and Bovine Serum Albumin
Immobilization
Regarding the immobilization of the capture antibody
(anti-PSA) on the AuNPs/HDT/Au electrode, several
concentrations of antibody solution were tested (Figure S3
in Supplementary Data).
The antibody immobilization caused a large reduction
of the Fe(CN)6
3/4 signal because of it forms a protein
layer that blocked the electrode surface and therefore,
hampered the electron transfer. The signal decreased with
the increase of the antibody concentration. For
10 mgmL1, the decrease of the signal was significant while
for higher concentrations, the electrode surface seemed to
be saturated. So, in order to assure a high surface
coverage, 10 mgmL1 was chosen as optimum antibody
concentration.
After the immobilization of the antibody, a blocking
step of the free surface sites of the anti-PSA/AuNPs/
HDT/Au electrode was carried out in order to avoid non-
specific binding of the PSA onto the electrode surface.
This blocking step consisted of immobilizing BSA onto
the electrode surface. BSA immobilization generated
Fig. 2. Square-wave voltammograms recorded at a scan rate of
200 mVs1 in 10 mM Fe(CN)6
3/4 solution (in PBS 0.1 M pH 7.4)
with the bare (Au) and the modified electrode with hexanedithiol
(HDT) employing 1 h (HDT/Au – 1 h) and 2 h (HDT/Au – 2 h)
as incubation time.
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another insulating protein layer on the anti-PSA/AuNPs/
HDT/Au electrode, hindering the electron transfer. This
step caused 28% of peak current reduction vs. the peak
current for anti-PSA/AuNPs/HDT/Au electrode (when
SWV is used) (Figure S4). These results proved that both,
anti-PSA and BSA, were successfully immobilized on the
AuNPs/HDT/Au electrode.
3.2 Electroanalytical Performance of the Immunosensor
Applying the optimized immunosensor (BSA/anti-PSA/
AuNPs/HDT/Au), the peak current decreased in the
presence of increased concentrations of PSA, due to the
block of the electron transport as a result of the capture
of the PSA by its antibody (Figure 4). Simultaneously, this
capture also promoted a slight negative shift of the peak
potential, when the antigen concentrations were aug-
mented, due to the modification of the interface proper-
ties of the biosensor surface. Still, the peak current
reduction showed a linear increase vs. log of PSA
concentrations in the range between 0.2 and 200 ngmL1
(Figure 4). The calibration curve presented wide linearity,
good sensitivity (slope=22.7% reduction mL ng1), data
Fig. 3. (A) Cyclic voltammograms recorded in 10 mM
FeðCNÞ3=46 solution (in PBS 0.1 M pH 7.4), at 50 mVs1, with
the bare electrode (Au), the electrode modified with hexanedi-
thiol (HDT/Au) and AuNPs (AuNPs/HDT/Au). (B,C) Scanning
electron microscopy images of the bare Au electrode (B) and
AuNPs/HDT/Au electrode (C). (D) Energy dispersive spectrum
of the AuNPs/HDT/Au electrode.
Fig. 4. Calibration data for the immunosensor based on the
square-wave cathodic peak current reduction (IpR; %) using
10 mM Fe(CN)6
3/4 solution (in PBS 0.1 M pH 7.4) as electro-
active indicator: (A) Calibration plot (0.2, 0.4, 0.6, 0.8, 1, 4, 6, 10,
20, 50, 100, 200 ngmL1 of PSA); error bars correspond to the
standard deviation of 6 measurements; (B) Representative
square-wave voltammograms (0.4 to 50 ngmL1 of PSA).
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well-distributed with low standard deviation (<13%) and
a correlation coefficient (r) of 0.990. The limit of detection
(LOD) was calculated as the lowest concentration of PSA
that gives a peak current three times higher than the
standard deviation of the analytical signal obtained in
absence of PSA under identical conditions [53]. The LOD
value thus obtained was 0.01 ngmL1 while the limit of
quantification (LOQ, ten times the standard deviation of
the blank) was 0.03 ngmL1. The reproducibility of the
immunosensor was also evaluated using six different
modified electrodes and a RSD of 5% was attained for
50 ngmL1 PSA concentration. The reached broad con-
centration range, low LOD and the good reproducibility
show that this simple immunosensor presents appropriate
analytical features for PSA detection.
Table 1 displays the electroanalytical characteristics of
recent reported electrochemical immunosensor for PSA
detection and those of the developed immunosensor. As it
can be seen, the proposed immunosensor improves the
width of the concentration range and the LOD in
comparison with some of the recent reported sensors
[27,28,45–47]. Although other immunosensors show lower
LOD that the achieved in this work [29,32,48–51]
(Table 1), it has to be considered that the construction of
these biosensors involves more complex schemes and
higher costs (since more materials, reagents and/or steps
are needed). Moreover, from a clinical point of view, a
wider concentration range or a LOD lower that the
achieved by our immunosensor have no real utility (since
the clinical threshold level is 2.5–4 ngmL1). Therefore,
the electroanalytical characteristics combined with the
simplicity of the proposed immunosensor make this
approach an interesting tool for PSA determination; even
more considering the label-free detection, which avoids
the need of expensive enzyme-linked antibody for recog-
nition or functionalized nanomaterials for signal augmen-
tation, decreasing the design complexity and cost.
The reusability of the biosensor was additionally
assessed. The immunosensor, once used for 10 ngmL1
PSA detection, was immersed in 0.1 M glycine-HCl
solution pH 3 for 20 minutes with the aim of breaking the
antibody-antigen linkage, and then it was applied for PSA
detection over again. It retained 86% of its initial signal
after 12 cycles of utilizations (measurement always fol-
lowed by regeneration), demonstrating the success of the
process. This feature is clearly an advantage when
compared to the previously reported biosensors for PSA
Table 1. Comparison of analytical properties of different electrochemical immunosensors for PSA detection.
Transducer Construction Detection Concentration
range
(ngmL1)
LOD
(ngmL1)
Ref.
Gold electrode HDT SAM/AuNPs/anti-PSA. Label free. SWV 0.2–200 0.01 This
work
8-channel
SPCEs
Streptavidin-coated magnetic beads and biotinylated anti-PSA.
Sandwich assay. HRP as label.
Amperometry 5–100 1.86 [27]
Gold electrode Cysteine SAM/Anti-PSA. Sandwich assay. scFv detection anti-
body-conjugated PtNPs. Label free.
Amperometry 1–30 0.03 [28]
Gold electrode OEGMA-co-GMA/AuNPs/Anti-PSA. Sandwich assay. Detection
antibody- conjugated SiNPs. Label free.
DPV 0.005–1000 0.002 [29]
Gold electrode CYS SAM/Fc cored PAMAM/anti-PSA. Label free. DPV 0.01–100 0.001 [32]
Glassy carbon
electrode
Silver hybridized mesoporous silica nanoparticles/Anti-PSA. Label
free.
CV 0.05–50 0.015 [45]
Glassy carbon
electrode
SP-modified rGO nanosheets/anti-PSA. Label free. DPV 0.1–5; 5–80 0.053 [46]
Pencil graphite
electrode
Peptide nanotube/AuNPs/PANI modified electrode. Sandwich
assay. HRP as label.
Amperometry 1–100 0.68 [47]
3D origami pa-
per SPCE
MnO2 nanowires electrodeposited on WE with AuNPs layer.
Sandwich assay. GOX and detection antibodies attached on carbon
nanospheres.
DPV 0.005–100 0.0012 [48]
Gold electrode MWCNTs/AuNPs/anti-PSA. Sandwich assay. HRP molecules and
detection antibody attached on MWCNTs.
SWV 0.001–10 0.0004 [49]
Paper-based
carbon elec-
trode
Anti-PSA on gold nanorods modified paper electrode. Sandwich
assay. Porous zinc oxide spheres-AgNPs as label.
Amperometry 0.004–60 0.0015 [50]
Gold electrode 6-mercapto-b-cyclodextrin SAM/anti-PSA. Label free. DPV 0.001–1 0.0003 [51]
Gold SPE TCNQ/Cu–MOF/anti-PSA. Label free. Conductometry 0.1–100 0.06 [52]
SPCE: screen-printed carbon electrode; SPE: screen-printed electrode; LSV: linear sweep voltammetry; CV: cyclic voltammetry; WE:
working electrode; PtNPs: platinum nanoparticles; Fc: ferrocene, PAMAM: polyamidiamine dendrimers; PANI: polyaniline; rGO:
reduced graphene oxide; SP: silk peptide; OEGMA-co-GMA: (oligo/ethylene glycol)methacrylate-co-glycidyl methacrylate; AgNPs:
silver nanoparticles; SiNPs: silica nanoparticles; MWCNTs: multiwalled carbon nanotubes; TCNQ: tetracyanoquinodimethante; MOF:
metal organic framework.
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detection that are usually designed to be used only one
time [32,45–47,49].
4 Conclusions
A simple immunosensor based on a modified gold
electrode has been developed for label-free voltammetric
analysis of PSA. The construction of the proposed
biosensor consists of a HDT self-assembled monolayer
forming an organized and packed layer on the surface of a
gold electrode, which enabled a fast and successful
modification with AuNPs. These nanoparticles, due to
their excellent conducting characteristics, promoted the
electronic transfer between the mediator and the elec-
trode surface amplifying the signal of the electrochemical
reaction. Thus, an immunosensor with low detection limit,
broad linearity range and suitable reproducibility was
achieved. The main advantages of the proposed immuno-
sensor are its simplicity and low-cost construction, as well
as the required relatively inexpensive instrumentation.
The linear range achieved makes this immunosensor
useful for PSA determination in clinical samples.
Acknowledgements
The authors are grateful for financial support from the
European Union (FEDER funds through COMPETE)
and National Funds (FCT) through projects UID/QUI/
50006/2013 and UID/CTM/50011/2013. The authors also
thank financial support by Norte Portugal Regional
Operational Programme (NORTE 2020), under the
PORTUGAL 2020 Partnership Agreement, through the
European Regional Development Fund (ERDF): projects
Norte-01-0145-FEDER-000011, Norte-01-0145-FEDER-
000024 and POCI-01-0145-FEDER-007679.
References
[1] World Heal. Organ. Int. Agency Res. Cancer. Glob. Cancer
Obs. (GCO). http//gco.iarc.fr/ (accessed 18.06.18) n.d.
[2] C. K. Zhou, D. P. Check, J. Lortet-Tieulent, M. Laversanne,
A. Jemal, J. Ferlay, F. Bray, M. B. Cook, S. S. Devesa, Int. J.
Cancer 2016, 138, 1388–1400.
[3] A. Barve, W. Jin, K. Cheng, J. Controlled Release 2014, 187,
118–132.
[4] E. C. Rama, A. Costa-Garcı´a, Electroanalysis 2016, 28,
1700–1715.
[5] K. C. Cary, M. R. Cooperberg, Ther. Adv. Urol. 2013, 5, 318–
329.
[6] X. Sun, C. Lei, L. Guo, Y. Zhou, Microchim. Acta 2016, 183,
2385–2393.
[7] A. H. Khan, E. Sadroddiny, Mol. Cell. Probes 2016, 30, 106–
112.
[8] E. Burcu Bahadir, M. Kemal Sezgintu¨rk, Talanta 2015, 132,
162–174.
[9] C. Kokkinos, A. Economou, M. I. Prodromidis, TrAC Trends
Anal. Chem. 2016, 79, 88–105.
[10] F. Arduini, L. Micheli, D. Moscone, G. Palleschi, S.
Piermarini, F. Ricci, G. Volpe, TrAC Trends Anal. Chem.
2016, 79, 114–126.
[11] D. G. A. Cabral, E. C. S. Lima, P. Moura, R. F. Dutra,
Talanta 2016, 148, 209–215.
[12] X. Liu, W. Li, L. Li, Y. Yang, L. Mao, Z. Peng, Sens.
Actuators B Chem. 2014, 191, 408–414.
[13] P. Carneiro, J. Loureiro, C. Delerue-Matos, S. Morais, M. do
Carmo Pereira, Sens. Actuators B Chem. 2017, 239, 157–165.
[14] C. Vericat, M. E. Vela, G. Benitez, P. Carro, R. C. Salvarezza,
Chem. Soc. Rev. 2010, 39, 1805–1834.
[15] N. K. Chaki, K. Vijayamohanan, Biosens. Bioelectron. 2002,
17, 1–12.
[16] M. C¸. Canbaz, C¸. S. S¸ims¸ek, M. K. Sezgintu¨rk, Anal. Chim.
Acta 2014, 814, 31–38.
[17] A. M. Mahmoud, T. Tang, D. Jed Harrison, W. E. Lee, A. B.
Jemere, Biosens. Bioelectron. 2014, 56, 328–333.
[18] V. Y. Kutsenko, Y. Y. Lopatina, L. Bossard-Giannesini, O. A.
Marchenko, O. Pluchery, S. V. Snegir, Nanotechnology 2017,
28, 235603.
[19] J. M. Pingarro´n, P. Ya´n˜ez-Seden˜o, A. Gonza´lez-Corte´s,
Electrochim. Acta 2008, 53, 5848–5866.
[20] S. Guo, E. Wang, Anal. Chim. Acta 2007, 598, 181–192.
[21] J. Fei, W. Dou, G. Zhao, Microchim. Acta 2015, 182, 2267–
2275.
[22] E. C. Rama, M. B. Gonza´lez-Garcı´a, A. Costa-Garcı´a, Sens.
Actuators B Chem. 2014, 201, 567–571.
[23] R. C. B. Marques, S. Viswanathan, H. P. A. Nouws, C.
Delerue-Matos, M. B. Gonza´lez-Garcı´a, Talanta 2014, 129,
594–599.
[24] V. Escamilla-Go´mez, D. Herna´ndez-Santos, M. B. Gonza´lez-
Garcı´a, J. M. Pingarro´n-Carrazo´n, A. Costa-Garcı´a, Biosens.
Bioelectron. 2009, 24, 2678–2683.
[25] G. K. Ahirwal, C. K. Mitra, Biosens. Bioelectron. 2010, 25,
2016–2020.
[26] K. Matsumoto, N. Konishi, Y. Hiasa, E. Kimura, Y.
Takahashi, K. Shinohara, T. Samori, Clin. Chim. Acta 1999,
281, 57–69.
[27] J. Biscay, M. B. Gonza´lez Garcı´a, A. C. Garcı´a, Electro-
analysis 2015, 27, 2773–2777.
[28] E. Spain, S. Gilgunn, S. Sharma, K. Adamson, E. Carthy, R.
O’Kennedy, R. J. Forster, Biosens. Bioelectron. 2016, 77,
759–766.
[29] S. Rafique, W. Bin, A. S. Bhatti, Bioelectrochemistry 2015,
101, 75–83.
[30] J. H. Lee, J. E. R. Rho, T. H. D. Rho, J. G. Newby, Biosens.
Bioelectron. 2010, 26, 377–382.
[31] K. Ito, W. Nishimura, M. Maeda, K. Gomi, S. Inouye, H.
Arakawa, Anal. Chim. Acta 2007, 588, 245–251.
[32] E. C¸evik, O¨. Bahar, S¸. Mehmet, M. F. Abas, Biosens.
Bioelectron. 2016, 86, 1074–1079.
[33] J. Turkevich, P. C. Stevenson, J. Hillier, Discuss. Faraday Soc.
1951, 11, 55–75.
[34] D. Qu, B.-C. Kim, C.-W. J. Lee, M. Ito, H. Noguchi, K.
Uosaki, J. Phys. Chem. C 2010, 114, 497–505.
[35] A. Ahmad, E. Moore, Analyst 2012, 137, 5839.
[36] P. Jolly, N. Formisano, J. Tka´cˇ, P. Kasa´k, C. G. Frost, P.
Estrela, Sens. Actuators B Chem. 2015, 209, 306–312.
[37] S. Chunta, J. Suk-Anake, K. Chansiri, C. Promptmas, Analyst
2014, 139, 4586.
[38] W. Wang, X. Ding, Q. Xu, J. Wang, L. Wang, X. Lou,
Colloids Surf. B Biointerfaces 2016, 148, 541–548.
[39] A. Majzik, R. Patakfalvi, V. Hornok, I. De´ka´ny, Gold Bull.
2009, 42, 113–123.
[40] I. Almeida, V. C. Ferreira, M. F. Montemor, L. M. Abrantes,
A. S. Viana, Electrochim. Acta 2012, 83, 311–320.
[41] S. Link, M. A. El-Sayed, J. Phys. Chem. B 1999, 103, 4212.
[42] V. C. Ferreira, A. F. Silva, L. M. Abrantes, J. Phys. Chem. C
2010, 114, 7710–7716.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
[43] J. N. Chazalviel, P. Allongue, J. Am. Chem. Soc. 2011, 133,
762–764.
[44] J. B. Shein, L. M. H. Lai, P. K. Eggers, M. N. Paddon-Row,
J. J. Gooding, Langmuir 2009, 25, 11121–11128.
[45] H. Wang, Y. Zhang, H. Yu, D. Wu, H. Ma, H. Li, B. Du, Q.
Wei, Anal. Biochem. 2013, 434, 123–127.
[46] Y. Wang, Y. Qu, G. Liu, X. Hou, Y. Huang, W. Wu, K. Wu,
C. Li,Microchim. Acta 2015, 182, 2061–2067.
[47] T. Vural, Y. T. Yaman, S. Ozturk, S. Abaci, E. B. Denkbas, J.
Colloid Interface Sci. 2018, 510, 318–326.
[48] L. Li, J. Xu, X. Zheng, C. Ma, X. Song, S. Ge, J. Yu, M. Yan,
Biosens. Bioelectron. 2014, 61, 76–82.
[49] R. Akter, M. A. Rahman, C. K. Rhee, Anal. Chem. 2012, 84,
6407–6415.
[50] G. Sun, H. Liu, Y. Zhang, J. Yu, M. Yan, X. Song, W. He,
New J. Chem. 2015, 39, 6062–6067.
[51] H. Deng, J. Li, Y. Zhang, H. Pan, G. Xu, Anal. Chim. Acta
2016, 926, 48–54.
[52] S. K. Bhardwaj, A. L. Sharma, N. Bhardwaj, M. Kukkar,
A. A. S. Gill, K. H. Kim, A. Deep, Sens. Actuators B Chem.
2017, 240, 10–17.
[53] J. N. Miller, J. C. Miller, Statistics and Chemometrics for
Analytical Chemistry, Pearson Prentice Hall, United King-
dom, 2005.
